| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.901 | |
| positive regulation of mrna 3 end processing | GO:0031442 | 12 | 0.845 | |
| hemoglobin metabolic process | GO:0020027 | 3 | 0.795 | |
| regulation of hemoglobin biosynthetic process | GO:0046984 | 1 | 0.785 | |
| response to calcium ion | GO:0051592 | 46 | 0.737 | |
| s shaped body morphogenesis | GO:0072050 | 4 | 0.726 | |
| embryonic viscerocranium morphogenesis | GO:0048703 | 1 | 0.681 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.668 | |
| locomotory behavior | GO:0007626 | 1 | 0.619 | |
| negative regulation of humoral immune response | GO:0002921 | 7 | 0.544 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 125 | 0.516 | |
| cell migration involved in sprouting angiogenesis | GO:0002042 | 19 | 0.515 | |
| endothelial cell migration | GO:0043542 | 86 | 0.494 | |
| internal protein amino acid acetylation | GO:0006475 | 101 | 0.479 | |
| cranial nerve development | GO:0021545 | 4 | 0.476 | |
| mapk cascade | GO:0000165 | 288 | 0.459 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.441 | |
| blastocyst formation | GO:0001825 | 3 | 0.420 | |
| apoptotic mitochondrial changes | GO:0008637 | 57 | 0.416 | |
| post embryonic development | GO:0009791 | 2 | 0.414 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.407 | |
| cellular response to oxidative stress | GO:0034599 | 85 | 0.403 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.397 | |
| smad protein signal transduction | GO:0060395 | 10 | 0.376 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.368 | |
| response to camp | GO:0051591 | 25 | 0.361 | |
| rhythmic behavior | GO:0007622 | 2 | 0.355 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.352 | |
| cellular response to heparin | GO:0071504 | 2 | 0.349 | |
| response to mechanical stimulus | GO:0009612 | 51 | 0.342 | |
| mitochondrial outer membrane permeabilization involved in programmed cell death | GO:1902686 | 16 | 0.333 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.326 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 17 | 0.321 | |
| regulation of cell proliferation involved in kidney development | GO:1901722 | 3 | 0.318 | |
| metanephric s shaped body morphogenesis | GO:0072284 | 4 | 0.299 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.291 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.284 | |
| response to heparin | GO:0071503 | 3 | 0.284 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.283 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 18 | 0.278 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.275 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 94 | 0.273 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.272 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.269 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.267 | |
| positive regulation of cell proliferation involved in kidney development | GO:1901724 | 1 | 0.265 | |
| cellular response to calcium ion | GO:0071277 | 19 | 0.260 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.259 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.255 | |
| positive regulation of mrna catabolic process | GO:0061014 | 10 | 0.254 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.250 | |
| rna processing | GO:0006396 | 255 | 0.246 | |
| trophectodermal cell differentiation | GO:0001829 | 3 | 0.243 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.237 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.230 | |
| negative regulation of response to external stimulus | GO:0032102 | 83 | 0.225 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.222 | |
| amine metabolic process | GO:0009308 | 44 | 0.219 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.219 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 57 | 0.217 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.217 | |
| membrane organization | GO:0061024 | 292 | 0.215 | |
| response to organophosphorus | GO:0046683 | 41 | 0.212 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.209 | |
| ectoderm development | GO:0007398 | 3 | 0.206 | |
| 3 utr mediated mrna destabilization | GO:0061158 | 1 | 0.203 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.197 | |
| positive regulation of hemoglobin biosynthetic process | GO:0046985 | 1 | 0.194 | |
| regulation of neuronal synaptic plasticity | GO:0048168 | 1 | 0.193 | |
| blood vessel development | GO:0001568 | 172 | 0.192 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.191 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.188 | |
| protein acetylation | GO:0006473 | 116 | 0.186 | |
| axon regeneration | GO:0031103 | 1 | 0.184 | |
| response to metal ion | GO:0010038 | 84 | 0.179 | |
| bmp signaling pathway | GO:0030509 | 49 | 0.178 | |
| regulation of mrna catabolic process | GO:0061013 | 13 | 0.177 | |
| chemokine c x c motif ligand 2 production | GO:0072567 | 3 | 0.177 | |
| positive regulation of ras gtpase activity | GO:0032320 | 117 | 0.176 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 36 | 0.175 | |
| blood vessel endothelial cell migration | GO:0043534 | 42 | 0.174 | |
| positive regulation of synaptic transmission | GO:0050806 | 4 | 0.173 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.172 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.171 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.171 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.170 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.165 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.163 | |
| jnk cascade | GO:0007254 | 80 | 0.162 | |
| regulation of glomerular mesangial cell proliferation | GO:0072124 | 3 | 0.161 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.160 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 23 | 0.157 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 41 | 0.157 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.155 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.153 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.152 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.152 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.150 | |
| circulatory system development | GO:0072359 | 262 | 0.150 | |
| visceral serous pericardium development | GO:0061032 | 1 | 0.150 | |
| mitochondrial transport | GO:0006839 | 60 | 0.148 | |
| metanephric nephron morphogenesis | GO:0072273 | 7 | 0.148 | |
| regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:1900151 | 8 | 0.147 | |
| single organism membrane organization | GO:0044802 | 268 | 0.145 | |
| regulation of viral process | GO:0050792 | 103 | 0.145 | |
| embryonic placenta development | GO:0001892 | 1 | 0.144 | |
| positive regulation of mitochondrial membrane permeability | GO:0035794 | 17 | 0.143 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.143 | |
| positive regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902110 | 16 | 0.143 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.142 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.141 | |
| histone acetylation | GO:0016573 | 93 | 0.141 | |
| mitochondrial membrane organization | GO:0007006 | 40 | 0.139 | |
| negative regulation by host of viral transcription | GO:0043922 | 12 | 0.139 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 0.138 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.137 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.136 | |
| modulation by host of symbiont transcription | GO:0052472 | 20 | 0.135 | |
| skeletal muscle cell differentiation | GO:0035914 | 6 | 0.135 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.133 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.130 | |
| somatic stem cell maintenance | GO:0035019 | 4 | 0.129 | |
| regulation of gastrulation | GO:0010470 | 12 | 0.127 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.126 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.126 | |
| response to steroid hormone | GO:0048545 | 80 | 0.125 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.124 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.123 | |
| oocyte differentiation | GO:0009994 | 2 | 0.123 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.123 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.123 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 85 | 0.122 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.121 | |
| negative regulation of multi organism process | GO:0043901 | 92 | 0.121 | |
| histone modification | GO:0016570 | 251 | 0.118 | |
| forebrain neuron development | GO:0021884 | 2 | 0.118 | |
| cell development | GO:0048468 | 328 | 0.118 | |
| gtp catabolic process | GO:0006184 | 237 | 0.117 | |
| response to growth factor | GO:0070848 | 205 | 0.116 | |
| viral process | GO:0016032 | 146 | 0.116 | |
| long term synaptic potentiation | GO:0060291 | 1 | 0.116 | |
| response to reactive oxygen species | GO:0000302 | 61 | 0.116 | |
| rna 3 end processing | GO:0031123 | 35 | 0.115 | |
| glomerular basement membrane development | GO:0032836 | 3 | 0.115 | |
| negative regulation of map kinase activity | GO:0043407 | 27 | 0.113 | |
| tissue migration | GO:0090130 | 119 | 0.113 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.113 | |
| regulation of membrane permeability | GO:0090559 | 25 | 0.112 | |
| regulation of mitochondrial membrane permeability | GO:0046902 | 25 | 0.112 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.111 | |
| translation | GO:0006412 | 132 | 0.111 | |
| rna stabilization | GO:0043489 | 18 | 0.111 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.111 | |
| cell proliferation involved in kidney development | GO:0072111 | 3 | 0.111 | |
| single organism cell adhesion | GO:0098602 | 179 | 0.110 | |
| collateral sprouting | GO:0048668 | 2 | 0.110 | |
| gene silencing by mirna | GO:0035195 | 23 | 0.110 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.110 | |
| oogenesis | GO:0048477 | 2 | 0.110 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 24 | 0.107 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.106 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.105 | |
| negative regulation of transcription from rna polymerase ii promoter in response to endoplasmic reticulum stress | GO:1990441 | 1 | 0.104 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.104 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.104 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.102 | |
| negative regulation of viral transcription | GO:0032897 | 23 | 0.100 | |
| neuron projection regeneration | GO:0031102 | 1 | 0.098 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.098 | |
| blood circulation | GO:0008015 | 113 | 0.096 | |
| glomerular mesangial cell proliferation | GO:0072110 | 3 | 0.095 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.094 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.094 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.092 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.091 | |
| metanephros morphogenesis | GO:0003338 | 9 | 0.090 | |
| oocyte development | GO:0048599 | 1 | 0.089 | |
| regulation of rho gtpase activity | GO:0032319 | 66 | 0.089 | |
| neurogenesis | GO:0022008 | 169 | 0.088 | |
| fibroblast apoptotic process | GO:0044346 | 8 | 0.087 | |
| negative regulation of transcription from rna polymerase ii promoter in response to stress | GO:0097201 | 5 | 0.087 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.087 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.087 | |
| regulation of viral transcription | GO:0046782 | 34 | 0.087 | |
| regulation of rho protein signal transduction | GO:0035023 | 79 | 0.086 | |
| regeneration | GO:0031099 | 4 | 0.086 | |
| nerve development | GO:0021675 | 4 | 0.086 | |
| heart contraction | GO:0060047 | 62 | 0.085 | |
| response to radiation | GO:0009314 | 151 | 0.085 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.084 | |
| oocyte maturation | GO:0001556 | 1 | 0.084 | |
| cellular response to external stimulus | GO:0071496 | 111 | 0.084 | |
| nuclear transport | GO:0051169 | 179 | 0.083 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.082 | |
| neuromuscular junction development | GO:0007528 | 3 | 0.081 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.081 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 185 | 0.081 | |
| female gamete generation | GO:0007292 | 2 | 0.081 | |
| nuclear transcribed mrna poly a tail shortening | GO:0000289 | 8 | 0.080 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.080 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 186 | 0.080 | |
| lymphocyte activation | GO:0046649 | 133 | 0.080 | |
| response to endoplasmic reticulum stress | GO:0034976 | 49 | 0.079 | |
| immune system development | GO:0002520 | 195 | 0.078 | |
| negative regulation of erk1 and erk2 cascade | GO:0070373 | 14 | 0.076 | |
| epithelium migration | GO:0090132 | 119 | 0.076 | |
| mesonephros development | GO:0001823 | 17 | 0.076 | |
| rho protein signal transduction | GO:0007266 | 26 | 0.075 | |
| mrna destabilization | GO:0061157 | 1 | 0.075 | |
| embryo development | GO:0009790 | 123 | 0.074 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.074 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 8 | 0.074 | |
| negative regulation of transferase activity | GO:0051348 | 124 | 0.074 | |
| blastocyst development | GO:0001824 | 3 | 0.074 | |
| regulation of defense response | GO:0031347 | 154 | 0.074 | |
| regulation of glomerulus development | GO:0090192 | 3 | 0.073 | |
| hemopoiesis | GO:0030097 | 180 | 0.073 | |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.071 | |
| endocytosis | GO:0006897 | 159 | 0.071 | |
| regulation of translation | GO:0006417 | 89 | 0.071 | |
| regulation of map kinase activity | GO:0043405 | 108 | 0.070 | |
| embryonic cranial skeleton morphogenesis | GO:0048701 | 6 | 0.070 | |
| guanosine containing compound catabolic process | GO:1901069 | 239 | 0.070 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.069 | |
| negative regulation of response to wounding | GO:1903035 | 47 | 0.069 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.069 | |
| positive regulation of viral process | GO:0048524 | 37 | 0.068 | |
| single organism cellular localization | GO:1902580 | 332 | 0.068 | |
| nuclear transcribed mrna catabolic process | GO:0000956 | 48 | 0.068 | |
| single organism nuclear import | GO:1902593 | 104 | 0.068 | |
| sleep | GO:0030431 | 2 | 0.067 | |
| regulation of endothelial cell proliferation | GO:0001936 | 56 | 0.067 | |
| regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902108 | 18 | 0.067 | |
| regulation of system process | GO:0044057 | 101 | 0.067 | |
| cellular response to toxic substance | GO:0097237 | 4 | 0.067 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.067 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 35 | 0.067 | |
| response to other organism | GO:0051707 | 261 | 0.066 | |
| mitochondrion organization | GO:0007005 | 156 | 0.066 | |
| intracellular protein transport | GO:0006886 | 270 | 0.065 | |
| protein import | GO:0017038 | 130 | 0.065 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.064 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 89 | 0.064 | |
| positive regulation of mrna metabolic process | GO:1903313 | 19 | 0.064 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.063 | |
| glomerulus development | GO:0032835 | 15 | 0.063 | |
| regulation of neuron death | GO:1901214 | 56 | 0.063 | |
| mrna processing | GO:0006397 | 133 | 0.061 | |
| antimicrobial humoral response | GO:0019730 | 26 | 0.061 | |
| response to unfolded protein | GO:0006986 | 24 | 0.061 | |
| cell adhesion | GO:0007155 | 325 | 0.061 | |
| cellular response to mechanical stimulus | GO:0071260 | 39 | 0.060 | |
| regulation of antimicrobial humoral response | GO:0002759 | 1 | 0.060 | |
| stress activated mapk cascade | GO:0051403 | 93 | 0.059 | |
| regulation of myeloid cell differentiation | GO:0045637 | 81 | 0.058 | |
| heart process | GO:0003015 | 62 | 0.058 | |
| multi organism cellular process | GO:0044764 | 156 | 0.058 | |
| interspecies interaction between organisms | GO:0044419 | 156 | 0.058 | |
| viral life cycle | GO:0019058 | 132 | 0.057 | |
| regulation of leukocyte differentiation | GO:1902105 | 61 | 0.057 | |
| cellular response to hyperoxia | GO:0071455 | 4 | 0.057 | |
| nervous system development | GO:0007399 | 293 | 0.057 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.057 | |
| negative regulation of interleukin 8 biosynthetic process | GO:0045415 | 3 | 0.056 | |
| associative learning | GO:0008306 | 1 | 0.056 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.056 | |
| pericardium development | GO:0060039 | 2 | 0.056 | |
| protein localization to organelle | GO:0033365 | 280 | 0.056 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.056 | |
| regulation of angiogenesis | GO:0045765 | 92 | 0.056 | |
| protein import into nucleus | GO:0006606 | 104 | 0.056 | |
| chromatin modification | GO:0016568 | 298 | 0.056 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 205 | 0.055 | |
| protein acylation | GO:0043543 | 138 | 0.055 | |
| cellular response to camp | GO:0071320 | 21 | 0.055 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.054 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.054 | |
| circadian behavior | GO:0048512 | 2 | 0.054 | |
| cellular response to gonadotropin stimulus | GO:0071371 | 4 | 0.054 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.054 | |
| reactive nitrogen species metabolic process | GO:2001057 | 3 | 0.054 | |
| digestive system development | GO:0055123 | 75 | 0.053 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.053 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.053 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.053 | |
| positive regulation of gtp catabolic process | GO:0033126 | 166 | 0.052 | |
| system process | GO:0003008 | 349 | 0.052 | |
| cell activation | GO:0001775 | 213 | 0.052 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 9 | 0.052 | |
| positive regulation of metanephros development | GO:0072216 | 3 | 0.052 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.051 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.050 | |
| cellular response to abiotic stimulus | GO:0071214 | 117 | 0.050 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.050 | |
| limbic system development | GO:0021761 | 3 | 0.050 | |
| positive regulation of neuron death | GO:1901216 | 14 | 0.049 | |
| wound healing | GO:0042060 | 115 | 0.049 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.049 | |
| post embryonic hemopoiesis | GO:0035166 | 1 | 0.048 | |
| response to light stimulus | GO:0009416 | 87 | 0.048 | |
| response to purine containing compound | GO:0014074 | 40 | 0.048 | |
| osteoblast differentiation | GO:0001649 | 92 | 0.048 | |
| modulation by host of viral transcription | GO:0043921 | 20 | 0.048 | |
| response to alcohol | GO:0097305 | 64 | 0.048 | |
| adult locomotory behavior | GO:0008344 | 1 | 0.048 | |
| cellular response to radiation | GO:0071478 | 65 | 0.047 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.047 | |
| response to toxic substance | GO:0009636 | 37 | 0.047 | |
| positive regulation of multi organism process | GO:0043902 | 56 | 0.047 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.047 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.047 | |
| mitotic cell cycle checkpoint | GO:0007093 | 68 | 0.046 | |
| regulation of rna stability | GO:0043487 | 23 | 0.046 | |
| response to axon injury | GO:0048678 | 1 | 0.046 | |
| cellular response to inorganic substance | GO:0071241 | 45 | 0.046 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.045 | |
| regulation of synaptic plasticity | GO:0048167 | 3 | 0.045 | |
| pancreatic a cell differentiation | GO:0003310 | 1 | 0.045 | |
| response to cocaine | GO:0042220 | 1 | 0.045 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.044 | |
| hemoglobin biosynthetic process | GO:0042541 | 3 | 0.044 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.043 | |
| positive regulation of rho gtpase activity | GO:0032321 | 56 | 0.043 | |
| positive regulation of gtpase activity | GO:0043547 | 166 | 0.043 | |
| mitotic nuclear division | GO:0007067 | 119 | 0.043 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.043 | |
| metanephric glomerulus development | GO:0072224 | 2 | 0.043 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 47 | 0.043 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.043 | |
| regulation of ras gtpase activity | GO:0032318 | 128 | 0.043 | |
| cytokine biosynthetic process | GO:0042089 | 37 | 0.043 | |
| negative regulation of dna binding | GO:0043392 | 18 | 0.042 | |
| gene silencing | GO:0016458 | 49 | 0.042 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 76 | 0.042 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.042 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.042 | |
| rna interference | GO:0016246 | 4 | 0.042 | |
| nuclear import | GO:0051170 | 106 | 0.042 | |
| sensory organ development | GO:0007423 | 52 | 0.041 | |
| cell projection organization | GO:0030030 | 252 | 0.041 | |
| neuron death | GO:0070997 | 65 | 0.040 | |
| regulation of metanephros development | GO:0072215 | 4 | 0.040 | |
| mrna metabolic process | GO:0016071 | 175 | 0.040 | |
| immune response | GO:0006955 | 307 | 0.040 | |
| negative regulation of protein processing | GO:0010955 | 142 | 0.039 | |
| compound eye development | GO:0048749 | 1 | 0.039 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 41 | 0.039 | |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.039 | |
| response to lipid | GO:0033993 | 206 | 0.039 | |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.039 | |
| nephron tubule morphogenesis | GO:0072078 | 13 | 0.038 | |
| response to transforming growth factor beta | GO:0071559 | 94 | 0.038 | |
| cellular response to metal ion | GO:0071248 | 43 | 0.038 | |
| negative regulation of viral process | GO:0048525 | 66 | 0.037 | |
| cardiovascular system development | GO:0072358 | 262 | 0.037 | |
| hindbrain development | GO:0030902 | 3 | 0.037 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 118 | 0.036 | |
| circulatory system process | GO:0003013 | 113 | 0.036 | |
| internal peptidyl lysine acetylation | GO:0018393 | 97 | 0.036 | |
| response to wounding | GO:0009611 | 168 | 0.036 | |
| regulation of nucleoside metabolic process | GO:0009118 | 209 | 0.035 | |
| osteoblast proliferation | GO:0033687 | 8 | 0.035 | |
| cell cell signaling | GO:0007267 | 155 | 0.035 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.035 | |
| negative regulation of mapk cascade | GO:0043409 | 56 | 0.035 | |
| ossification | GO:0001503 | 121 | 0.034 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.034 | |
| cell cycle g2 m phase transition | GO:0044839 | 43 | 0.034 | |
| response to electrical stimulus | GO:0051602 | 1 | 0.034 | |
| regulation of response to biotic stimulus | GO:0002831 | 55 | 0.034 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.034 | |
| renal tubule development | GO:0061326 | 19 | 0.033 | |
| leukocyte activation | GO:0045321 | 164 | 0.033 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.033 | |
| regulation of gtpase activity | GO:0043087 | 180 | 0.033 | |
| striated muscle tissue development | GO:0014706 | 59 | 0.033 | |
| negative regulation of kinase activity | GO:0033673 | 106 | 0.033 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.033 | |
| cranial nerve morphogenesis | GO:0021602 | 1 | 0.032 | |
| cell morphogenesis | GO:0000902 | 296 | 0.032 | |
| erythrocyte differentiation | GO:0030218 | 28 | 0.032 | |
| osteoclast differentiation | GO:0030316 | 21 | 0.032 | |
| positive regulation of p38mapk cascade | GO:1900745 | 8 | 0.032 | |
| glomerulus vasculature development | GO:0072012 | 6 | 0.032 | |
| protein localization to nucleus | GO:0034504 | 136 | 0.032 | |
| gtp metabolic process | GO:0046039 | 239 | 0.031 | |
| metanephric nephron tubule morphogenesis | GO:0072282 | 1 | 0.031 | |
| modification of morphology or physiology of other organism | GO:0035821 | 43 | 0.031 | |
| neuroblast proliferation | GO:0007405 | 4 | 0.031 | |
| behavior | GO:0007610 | 112 | 0.030 | |
| muscle cell differentiation | GO:0042692 | 63 | 0.030 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.030 | |
| positive regulation of glomerulus development | GO:0090193 | 1 | 0.030 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.030 | |
| histone h3 k27 demethylation | GO:0071557 | 3 | 0.030 | |
| negative regulation of erythrocyte differentiation | GO:0045647 | 3 | 0.030 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.029 | |
| viral transcription | GO:0019083 | 35 | 0.029 | |
| neuron differentiation | GO:0030182 | 138 | 0.029 | |
| muscle structure development | GO:0061061 | 98 | 0.029 | |
| cell fate determination | GO:0001709 | 3 | 0.029 | |
| chordate embryonic development | GO:0043009 | 34 | 0.028 | |
| response to drug | GO:0042493 | 81 | 0.028 | |
| regulation of mrna 3 end processing | GO:0031440 | 12 | 0.028 | |
| hippocampus development | GO:0021766 | 1 | 0.028 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 156 | 0.028 | |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.028 | |
| negative regulation of endopeptidase activity | GO:0010951 | 84 | 0.028 | |
| response to bacterium | GO:0009617 | 144 | 0.027 | |
| somatic muscle development | GO:0007525 | 1 | 0.027 | |
| cellular response to ionizing radiation | GO:0071479 | 32 | 0.027 | |
| generation of neurons | GO:0048699 | 152 | 0.027 | |
| protein catabolic process | GO:0030163 | 325 | 0.027 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.027 | |
| regulation of immune response | GO:0050776 | 201 | 0.027 | |
| central nervous system neuron axonogenesis | GO:0021955 | 3 | 0.027 | |
| t cell activation | GO:0042110 | 99 | 0.027 | |
| regulation of cell migration | GO:0030334 | 289 | 0.027 | |
| viral gene expression | GO:0019080 | 35 | 0.027 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 4 | 0.027 | |
| neuron development | GO:0048666 | 113 | 0.027 | |
| positive regulation by host of viral transcription | GO:0043923 | 11 | 0.027 | |
| negative regulation of defense response | GO:0031348 | 47 | 0.027 | |
| innate immune response | GO:0045087 | 178 | 0.027 | |
| humoral immune response | GO:0006959 | 49 | 0.026 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 69 | 0.026 | |
| response to nitrosative stress | GO:0051409 | 4 | 0.026 | |
| response to hypoxia | GO:0001666 | 96 | 0.026 | |
| positive regulation of viral transcription | GO:0050434 | 13 | 0.026 | |
| response to ketone | GO:1901654 | 19 | 0.026 | |
| neurological system process | GO:0050877 | 163 | 0.026 | |
| protein targeting to nucleus | GO:0044744 | 104 | 0.026 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.026 | |
| ectodermal cell fate commitment | GO:0001712 | 1 | 0.026 | |
| vasculature development | GO:0001944 | 181 | 0.026 | |
| negative regulation of lipopolysaccharide mediated signaling pathway | GO:0031665 | 7 | 0.025 | |
| protein processing | GO:0016485 | 226 | 0.025 | |
| response to virus | GO:0009615 | 126 | 0.025 | |
| sprouting angiogenesis | GO:0002040 | 29 | 0.025 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.025 | |
| dna damage checkpoint | GO:0000077 | 68 | 0.025 | |
| regulation of nuclear transcribed mrna poly a tail shortening | GO:0060211 | 8 | 0.025 | |
| erk1 and erk2 cascade | GO:0070371 | 104 | 0.025 | |
| positive regulation of cellular protein catabolic process | GO:1903364 | 37 | 0.025 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.025 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.025 | |
| negative regulation of chemokine production | GO:0032682 | 9 | 0.025 | |
| negative regulation of protein kinase activity | GO:0006469 | 98 | 0.025 | |
| positive regulation of endothelial cell proliferation | GO:0001938 | 37 | 0.024 | |
| peptidyl tyrosine dephosphorylation | GO:0035335 | 36 | 0.024 | |
| macromolecule methylation | GO:0043414 | 97 | 0.024 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.024 | |
| monosaccharide metabolic process | GO:0005996 | 74 | 0.024 | |
| segmentation | GO:0035282 | 4 | 0.024 | |
| developmental growth | GO:0048589 | 48 | 0.024 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.024 | |
| angiogenesis | GO:0001525 | 147 | 0.024 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.024 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 69 | 0.024 | |
| metanephric epithelium development | GO:0072207 | 7 | 0.024 | |
| regulation of vasculature development | GO:1901342 | 97 | 0.024 | |
| response to oxidative stress | GO:0006979 | 121 | 0.024 | |
| regulation of cell division | GO:0051302 | 116 | 0.024 | |
| regulation of gtp catabolic process | GO:0033124 | 180 | 0.023 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 88 | 0.023 | |
| optic nerve development | GO:0021554 | 2 | 0.023 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.023 | |
| negative regulation of translation | GO:0017148 | 37 | 0.023 | |
| cell cycle checkpoint | GO:0000075 | 117 | 0.023 | |
| nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:0000288 | 14 | 0.023 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 156 | 0.023 | |
| cell growth | GO:0016049 | 160 | 0.023 | |
| head development | GO:0060322 | 108 | 0.023 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.023 | |
| t cell differentiation in thymus | GO:0033077 | 4 | 0.023 | |
| circadian rhythm | GO:0007623 | 21 | 0.023 | |
| response to cytokine | GO:0034097 | 232 | 0.022 | |
| positive regulation of acute inflammatory response | GO:0002675 | 2 | 0.022 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 39 | 0.022 | |
| forebrain neuron differentiation | GO:0021879 | 3 | 0.022 | |
| response to cycloheximide | GO:0046898 | 1 | 0.022 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 39 | 0.022 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.022 | |
| oligodendrocyte differentiation | GO:0048709 | 7 | 0.022 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.022 | |
| negative regulation of chemokine c x c motif ligand 2 production | GO:2000342 | 1 | 0.022 | |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO:0051817 | 38 | 0.022 | |
| negative regulation of nf kappab transcription factor activity | GO:0032088 | 51 | 0.022 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 55 | 0.022 | |
| regulation of cell growth | GO:0001558 | 135 | 0.022 | |
| negative regulation of phosphatidylinositol 3 kinase signaling | GO:0014067 | 4 | 0.022 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.022 | |
| ureteric bud morphogenesis | GO:0060675 | 10 | 0.022 | |
| nephron epithelium development | GO:0072009 | 23 | 0.022 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.021 | |
| developmental process involved in reproduction | GO:0003006 | 66 | 0.021 | |
| intra s dna damage checkpoint | GO:0031573 | 4 | 0.021 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 191 | 0.021 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.021 | |
| thymus development | GO:0048538 | 3 | 0.021 | |
